Your browser doesn't support javascript.
loading
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher, Toby M; Ford, Paul; Brown, Kevin K; Costabel, Ulrich; Cottin, Vincent; Danoff, Sonye K; Groenveld, Irene; Helmer, Eric; Jenkins, R Gisli; Milner, Julie; Molenberghs, Geert; Penninckx, Bjorn; Randall, Matthew J; Van Den Blink, Bernt; Fieuw, Ann; Vandenrijn, Charlotte; Rocak, Sanda; Seghers, Ineke; Shao, Lixin; Taneja, Amit; Jentsch, Garrit; Watkins, Timothy R; Wuyts, Wim A; Kreuter, Michael; Verbruggen, Nadia; Prasad, Niyati; Wijsenbeek, Marlies S.
Afiliación
  • Maher TM; National Heart and Lung Institute, Imperial College London, London, England.
  • Ford P; Keck School of Medicine, University of Southern California, Los Angeles.
  • Brown KK; Galapagos NV, Mechelen, Belgium.
  • Costabel U; National Jewish Health, Denver, Colorado.
  • Cottin V; Center for Interstitial and Rare Lung Diseases, Ruhrlandklinik University Hospital, University of Duisburg-Essen, Essen, Germany.
  • Danoff SK; Reference Center for Rare Pulmonary Diseases, Hôpital Louis Pradel, Hospices Civils de Lyon, and IVPC, INRAE, Claude Bernard University Lyon 1, Lyon, France.
  • Groenveld I; School of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Helmer E; Galapagos NV, Leiden, the Netherlands.
  • Jenkins RG; CellPoint BV, Oegstgeest, the Netherlands.
  • Milner J; Galapagos Biotech Ltd, Cambridge, England.
  • Molenberghs G; Exscientia, Oxford, England.
  • Penninckx B; National Heart and Lung Institute, Imperial College London, London, England.
  • Randall MJ; Gilead Sciences, Inc, Foster City, California.
  • Van Den Blink B; Alnylam, Maidenhead, England.
  • Fieuw A; Hasselt University, Hasselt, Belgium.
  • Vandenrijn C; KU Leuven, Leuven, Belgium.
  • Rocak S; Galapagos NV, Mechelen, Belgium.
  • Seghers I; Galapagos GmbH, Basel, Switzerland.
  • Shao L; Galapagos NV, Leiden, the Netherlands.
  • Taneja A; Galapagos NV, Mechelen, Belgium.
  • Jentsch G; Galapagos NV, Mechelen, Belgium.
  • Watkins TR; Galapagos GmbH, Basel, Switzerland.
  • Wuyts WA; Galapagos NV, Mechelen, Belgium.
  • Kreuter M; Argenx, Gent, Belgium.
  • Verbruggen N; Gilead Sciences, Inc, Foster City, California.
  • Prasad N; Galapagos SASU, Romainville, France.
  • Wijsenbeek MS; BAST GmbH, Heidelberg, Germany.
JAMA ; 329(18): 1567-1578, 2023 05 09.
Article en En | MEDLINE | ID: mdl-37159034
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos del Sistema Respiratorio / Fibrosis Pulmonar Idiopática Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fármacos del Sistema Respiratorio / Fibrosis Pulmonar Idiopática Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JAMA Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido